March 2015 FDA Recall Drug by Ultra Zx Supplements
D-0991-2015 - Marketed Without An Approved NDA/ANDA

This Class I drug recall was voluntarily initiated by Ultra Zx Supplements on March 10, 2015 for the product Drug. The FDA reported the reason for recall as marketed without an approved nda/anda. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0991-2015

Reason for Recall
Marketed Without An Approved NDA/ANDA: FDA laboratory analysis confirmed that ULTRA ZX contains undeclared sibutramine and phenolphthalein
Initiated
03-10-2015
Reported
05-13-2015
Quantity
636 bottles

Recall Profile & Regulatory Data

Class I - is a situation in which there is a reasonable probability that the use of, or exposure to, a violative product will cause serious adverse health consequences or death.
Ultra ZX Supplements
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Nationwide and Puerto Rico Foreign: Spain and Ecuador
ULTRA ZX DIETARY SUPPLEMENT (Extracto de Naranjo Amargo 70, Extracto de semilla de Sen 47.6, Lagrima de Coix 42, Almidon Medico 84), 30 capsule bottles, Manufactured and distributed by: Ultra ZX Labs, L.L.C. 2525 SW 3rd Ave Apt 1704 Miami, Florida 33129-2068.

Batch or Lot Expiration Information

Lot# All lots/codes/bottles/packages.